No. |
Product Name |
CAS No. |
Spec |
Price |
|
| 1270719 |
Flavoxate Related Compound A (25 mg) (3-methylflavone-8-carboxylic acid) |
3468-01-7 |
|
|
| 1270720 |
Flavoxate Related Compound B (20 mg) (3-Methylflavone-8-carboxylic acid methyl ester) |
90101-87-4 |
|
|
| 1270731 |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) |
35888-94-9 |
|
|
| 1270800 |
Flecainide Acetate (200 mg) |
54143-56-5 |
|
|
| 1270821 |
Flecainide Related Compound A (75 mg) (3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine hydrochloride) |
N/A |
|
|
| 1271008 |
Floxuridine (250 mg) |
50-91-9 |
|
|
| 1271700 |
Fluconazole (200 mg) |
86386-73-4 |
|
|
| 1271711 |
Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) |
N/A |
|
|
| 1271722 |
Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) |
81886-51-3 |
|
|
| 1271733 |
Fluconazole Related Compound C (10 mg) (1,1’-(1,3-phenylene)di(1H-1,2,4-triazole)) |
N/A |
|
|
| 1272000 |
Flucytosine (200 mg) |
2022-85-7 |
|
|
| 1272204 |
Fludarabine Phosphate (300 mg) |
75607-67-9 |
|
|
| 1272907 |
Fludeoxyglucose (100 mg) |
29702-43-0 |
|
|
| 1272918 |
Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) |
23978-09-8 |
|
|
| 1272929 |
Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose) |
14685-79-1 |
|
|
| 1273003 |
Fludrocortisone Acetate (200 mg) |
514-36-3 |
|
|
| 1273808 |
Flumazenil (200 mg) |
78755-81-4 |
|
|
| 1273819 |
Flumazenil Related Compound A (20 mg) (8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylic acid) |
N/A |
|
|
| 1273820 |
Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylate) |
N/A |
|
|
| 1273841 |
Flumazenil Related Compound C (500 mg) (N,N-Dimethylformamide diethyl acetal) |
1188-33-6 |
|
|
|
|
